Skip to main navigation Skip to search Skip to main content

The high-affinity IgG receptor, FcγRI, plays a central role in antibody therapy of experimental melanoma

Translated title of the contribution: The high-affinity IgG receptor, FcγRI, plays a central role in antibody therapy of experimental melanoma

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionThe high-affinity IgG receptor, FcγRI, plays a central role in antibody therapy of experimental melanoma
Original languageUndefined/Unknown
Pages (from-to)1261-1264
Number of pages4
JournalCancer Research
Volume66
Publication statusPublished - 2006

Cite this